Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,952.00
(
0.91%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
-2.31%
)
Bitcoin
78,274.43
(
2.55%
)
News Focus
News Focus
Post# of 144836
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

takeyouhigher

Send PM Follow Ignore
Followers 1
Posts 287
Boards Moderated 0
Alias Born 03/14/2016

takeyouhigher

Re: DragonBear post# 84859

Monday, 07/09/2018 5:35:59 PM

Monday, July 09, 2018 5:35:59 PM

Post# of 144836
You're exactly right. I noticed this presentation at ASCO as well.
It seems that standard gemcitabine/ plus nab-paclitaxel will no longer be standard of care. That means that PMCB's comparator arm in its make believe clinical trial will not be the standard treatment.
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent PMCB News
More PMCB News